Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often stress the possibility for significant therapeutic benefits, especially in diseases where conventional medications have proven limited. However, crucially important to consider the substantial financial investment associated with